| Primary Site | Total | Males | Females | |||
|---|---|---|---|---|---|---|
| Number | Rate | Number | Rate | Number | Rate | |
| All sites | 61 | 278.2 | 31 | 312.6 | 30 | 262.6 |
| Oral cavity and pharynx | * | # | * | # | * | # |
| Lip | * | # | * | # | * | # |
| Tongue | * | # | * | # | * | # |
| Major salivary glands | * | # | * | # | * | # |
| Floor of mouth | * | # | * | # | * | # |
| Gum and other mouth | * | # | * | # | * | # |
| Nasopharynx | * | # | * | # | * | # |
| Tonsil | * | # | * | # | * | # |
| Oropharynx | * | # | * | # | * | # |
| Hypopharynx | * | # | * | # | * | # |
| Pharynx and other oral cavity | * | # | * | # | * | # |
| Digestive system | 10 | 49.0** | 5 | 53.6** | 5 | 48.2** |
| Esophagus | * | # | * | # | * | # |
| Stomach | * | # | * | # | * | # |
| Small intestine | * | # | * | # | * | # |
| Colon excluding rectum | * | # | * | # | * | # |
| Rectum and rectosigmoid | * | # | * | # | * | # |
| Anus, anal canal, and anorectum | * | # | * | # | * | # |
| Liver and intrahepatic bile duct | * | # | * | # | * | # |
| Gallbladder | * | # | * | # | * | # |
| Other biliary | * | # | * | # | * | # |
| Pancreas | * | # | * | # | * | # |
| Retroperitoneum | * | # | * | # | * | # |
| Peritoneum | * | # | * | # | * | # |
| Other digestive organs | * | # | * | # | * | # |
| Respiratory system | 11 | 51.7** | 6 | 63.4** | 5 | 41.7** |
| Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
| Larynx | * | # | * | # | * | # |
| Lung and bronchus | 10 | 45.4** | 5 | 50.5** | 5 | 41.7** |
| Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
| Bones and joints | * | # | * | # | * | # |
| Soft tissue (including heart) | * | # | * | # | * | # |
| Skin (excluding basal and squamous) | * | # | * | # | * | # |
| Melanoma of the skin | * | # | * | # | * | # |
| Other non-epithelial skin cancers | * | # | * | # | * | # |
| Breast | 8 | 37.4** | * | # | ~ | 68.5** |
| Female genital system | -- | -- | -- | -- | * | # |
| Cervix uteri | -- | -- | -- | -- | * | # |
| Corpus uteri | -- | -- | -- | -- | * | # |
| Uterus, NOS | -- | -- | -- | -- | * | # |
| Ovary | -- | -- | -- | -- | * | # |
| Vagina | -- | -- | -- | -- | * | # |
| Vulva | -- | -- | -- | -- | * | # |
| Other female genital organs | -- | -- | -- | -- | * | # |
| Male genital system | -- | -- | ~ | 56.4** | -- | -- |
| Prostate gland | -- | -- | ~ | 56.4** | -- | -- |
| Testis | -- | -- | * | # | -- | -- |
| Penis | -- | -- | * | # | -- | -- |
| Other male genital organs | -- | -- | * | # | -- | -- |
| Urinary system | 7 | 32.2** | ~ | 48.0** | * | # |
| Urinary bladder | 6 | 27.7** | * | # | * | # |
| Kidney and renal pelvis | * | # | * | # | * | # |
| Ureter | * | # | * | # | * | # |
| Other urinary organs | * | # | * | # | * | # |
| Eye and orbit | * | # | * | # | * | # |
| Brain and other nervous system | * | # | * | # | * | # |
| Brain | * | # | * | # | * | # |
| Other nervous system | * | # | * | # | * | # |
| Endocrine system | * | # | * | # | * | # |
| Thyroid gland | * | # | * | # | * | # |
| Other endocrine (including thymus) | * | # | * | # | * | # |
| Lymphoma | * | # | * | # | * | # |
| Hodgkin's disease | * | # | * | # | * | # |
| Non-Hodgkin's lymphoma | * | # | * | # | * | # |
| Multiple myeloma | * | # | * | # | * | # |
| Leukemia | * | # | * | # | * | # |
| Acute lymphocytic | * | # | * | # | * | # |
| Chronic lymphocytic | * | # | * | # | * | # |
| Acute myeloid | * | # | * | # | * | # |
| Chronic myeloid | * | # | * | # | * | # |
| Other leukemias | * | # | * | # | * | # |
| Other, ill-defined and unknown sites | * | # | * | # | * | # |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ~ Opposite sex has fewer than 5 cases. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. Source : Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2003 |
||||||